Clinical trial
Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study
NCT00701727 is registered in ClinicalTrials.gov with Radiant Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study
- Lead sponsor
- Radiant Research
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- March 31, 2009
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.